Pharmacy Times January 19, 2022
Justin Lindhorst, MBA

Drug manufacturers participating in Medicaid offer lower prices, stretching resources and providing comprehensive services to more patients.

A recent report from the Commonwealth Fund puts the US health care system in last place compared with 11 other high-income countries.1

Despite spending the highest proportion of its gross domestic product on health care, the United States performed the worst in terms of access to care, administrative efficiency, health equity, and outcomes.1 Although the performance of the US health system affects all Americans, certain populations are at greater risk for health disparities based on their age, disability, ethnicity, gender, race, sexual identity, and socioeconomic status.2 Health disparities include, but are not limited to, differences in access to care, disease burden, life expectancy,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Insurance, Medicaid, Patient / Consumer, Pharma / Biotech, Provider, Survey / Study, Trends
Gilead bets on Xilio cancer drug as biotech restructures
Pfizer shifts creative to Publicis in latest marketing move
Boundless Bio’s ‘BOLD’ IPO Reels In $100M for a New Kind of Cancer Drug
Joseph La Barge On The Challenges Of Advancing Gene Therapy, Finding The Right Support
Walgreens Suffers $6 Billion Loss As VillageMD Clinic Investment Sours

Share This Article